. .,.. Experimental Evidence
A number of lines of evidence attest to the ability of xenobiotic materials to affect estrogen production (9) . Ovariectomy, which reduces endogenous hormones, inhibits the progression of chemically induced mammary tumors, whereas reintroduction of estrogen by implantation stimulates tumor development. Moreover, rat mammary cancers depend on both late and early exposure to estrogen and prolactin (11) .
Experimental studies indicate that estradiol metabolism proceeds primarily via two mutually exclusive pathways, each of which is affected by xenobiotic exposures: pathway I to 2-hydroxyestrone (2-OHEI), which has minimal estrogenic activity and is nongenotoxic, or pathway II to 16a-OHEI, a fully potent estrogen which is also genotoxic (12 (BaP) , oncogenes, and tumor virus exposure inhibit pathway I and also induce mammary tumors (13) . Dietary supplements that increase pathway I, such as indole-3-carbinol, also decrease mammary tumor incidence (14) , but those that induce pathway II, such as alcohol, tend to increase carcinogenic response (10, 15) . In addition to affecting pathway II, alcohol consumption has been shown to induce P450IIE and decrease P4501A1, subfamilies of enzymes key to the metabolism of other potential carcinogens (15) .
As to the role of dietary factors in estrogen production, a number of studies indicate that both fat and fiber intake modulates estrogen metabolism. Linoleic and arachidonic acids increase pathway II (12) .
A high-fiber diet, along with greater physi-cal exercise, reduces enterohepatic resorption of fecal estrogens (16) . Severe caloric restriction results in major increases in pathway I and reductions in pathway II (1X.
A variety of in vitro and in vivo studies have documented the estrogenicity of some lipophilic, bioconcentrated xenobiotics; that is, their ability to stimulate estrogen and function as xenoestrogens (Table 1) . Estrogens promote breast cell proliferation (18) and hypertrophy of other secondary sex organs (19) . Similar effects have been observed in fish, birds, and wildlife (9) . Xenoestrogenic substances include several lipophilic, persistent compounds for which human, food chain, and wildlife exposures have been widespread (20) . These chemicals include a number of chlorinated organics, such as o,p'-DDT, an isomer of the pesticide DDT, chlordecone, heptachlor, and other pesticides, polychlorinated biphenyls (PCBs), triazine herbicide, and a number of polycyclic aromatic hydrocarbons (PAH), compounds derived from petroleum products, fossil fuels, and products of incomplete combustion. In addition, some pharmaceutical agents such as diethylstilbestrol (DES) are direct estrogens, and others, such as tamoxifen, mimic estrogen in premenopausal women but block estrogen in postmenopausal women (21) . Still other pharmaceuticals, such as cimetidine, inhibit pathway I and stimulate breast cell proliferation (22) . Animals exposed to ambient levels of commonly encountered compounds one at a time, such as Aroclor 1254, a PCB, showed no adverse effects. But animals dosed with mixtures of ambient levels of commonly encountered groundwater contaminants, including PCBs and ubiquitous viruses, developed a variety of adverse effects on growth and reproduction (23) .
A number of xenoestrogenic compounds induce or promote breast cancer experimentally (24) . Primary carcinogenesis may also occur with other xenobiotics because human breast epithelial and fibroblastic cells metabolize them to carcinogenic electrophiles (25) . (29) .
Atrazine is of special interest, as it is a triazine herbicide that is one of the most commonly used pesticides in the United States today, and it is widely found in groundwater (30) . Atrazine is a stable compound that is retained in the abdominal fat Most of the known risk factors for breast cancer, which at best account for 30% of cases (2) are linked with total lifetime exposure to reproductive hormones (35) . Aside from genetics and radiation in premenopausal breast cancer, these risk factors include age, age at menarche, menopause, and first full-term pregnancy, total calorie intake, family history, height, radiation exposure, and alcohol intake (36) . Artificial reduction of hormones by ovariectomy before age 35 reduces human breast cancer risk (36) .
Diet influences estrogen production in various ways. A diet of proportionally higher total calories relative to body mass can also alter the metabolism of estrogen in the gut and stimulate earlier onset of menses. However, obese, premenopausal women who are amenorrheic have reduced risks of breast cancer, whereas obese postmenopausal women have higher risks, presumably due to the ability of body fat to enhance production of estrogens after menopause when ovarian production of estrogen diminishes rapidly (2) . Severe restriction of caloric intake appears to reduce the risk of breast cancer (37) , possibly by delaying the onset of menses or otherwise reducing total lifetime estrogen exposure.
The role of dietary fat for breast cancer remains the subject of a lively debate and inconsistent results. A meta-analysis of 12 case-control studies reported that the risk of breast cancer increased with increasing dietary fat and included some studies with more than a twofold difference (38) . Others have found no such association (39) .
Direct epidemiologic evidence linking chlorinated organics to breast cancer ranges from suggestive geographic and cross-sectional mortality analyses to case-control studies. A recent analysis of chemical plant workers found more than a twofold increase in breast cancer in female workers exposed to dioxin contamination (40) . Elevated breast cancer rates were also detected in an analysis of women exposed to extensive environmental contamination with PCBs in Japan (41) . In contrast, other studies have been negative (42, 43) .
Geographic and other large-scale analyses have suggested a link between breast cancer and PAH or chlorinated organic compounds but have not involved any direct measures of exposure (16) . Significantly elevated rates of breast cancer have been detected in one area of Minnesota where water was contaminated with PAHs (44, 45) . Women who work in the chemical industry (46) or who live near hazardous waste sites are also reported to have higher rates of breast cancer (47) . Another study reported a temporal association between a decrease in population exposure to chlorinated organics and a reduction in breast cancer mortality rates (16) .
As Table 3 reveals, most of the negative analytic studies have involved fewer than 10 cases and have had only about a 30% chance of detecting a twofold difference in risk (48) . Several more recent studies have provided evidence that chlorinated organics are linked to breast cancer. In one study, the breast fat of women with cancer at biopsy had about 40% more of some chlorinated pesticides such as metabolites of DDT and elevated levels of PCB (49) . About 50% more hexachlorocyclohexane (50) was detected in pooled blood from breast cancer cases compared to a pooled reference group, controlling for age and parity.
Further resolution of the role of chlorinated organics comes from a well-designed study that matched on several factors and adjusted for a number of confounders. This recent nested case-control study of 58 prospectively gathered cases was drawn from a cohort of 14,000 women. Women at the 90th percentile of DDE in serum had a fourfold greater risk of breast cancer compared to those at the 10th percentile (51) . PCB levels also differed, but this difference was not statistically significant. Two other case-control studies are also germane involving ovarian cancer, which is also hormonally mediated. A hospitalbased case-control study in Italy detected a significant link between herbicides and ovarian cancer but could not pinpoint specific exposures (52) . A population-based case-control study which (53) .
Hypothesis
A variety of experimental and human evidence indicates that the greater the total lifetime exposure to bioavailable estrogen, the greater the risk for breast cancer. In light of the pivotal role of estrogen, we hypothesize that exposure to some xenoestrogens elevates endogenous hormone levels, especially 16x-OHE1, which stimulate breast cell proliferation and thereby induce or promote breast cancer. Xenobiotic compounds could alter bioactive estrogen or progesterone in breast cancer cases or otherwise induce mammary carcinogenesis through the P450 enzymes. Those with genetic susceptibility to breast cancer might be exquisitely sensitive to the proliferative effects of xenoestrogenic substances in the environment.
Xenoestrogenic compounds may work through several estrogen-related mechanisms or through other mechanisms unrelated to estrogen (Fig. 1) . Environmental chemicals may be directly estrogenic, as is o,p'-DDT. Or they may alter estradiol metabolism, or otherwise enhance the production of 16a-OHE1 (pathway II) or reduce the production of 2-OHEI (pathway I), as occurs with some drugs such as cimetidine. In (54) . In some families with the rare, autosomal dominant Li- Fraumeni syndrome (55) , a high breast cancer risk is due to the inheritance of a specific cancer-predisposing mutation on chromosome 17q2l (56, 57) . Results of a recent population study suggest that more than 6.5 women per 1000 with breast cancer are carriers of another inherited breast cancer-predisposing mutation in a series of codons on chromosome 17 (54) .
As the proportion of inherited breast cancer in the population is small (58) , most breast cancers result from acquired mutations, possibly stemming from xenoestrogens or from environmental carcinogens that affect pathways other than estrogen. This hypothesis suggests that it is important to study genetic-environmental interactions to identify environmental factors that influence gene expression in the great majority of acquired mutations.
Two lines of evidence are pinpointing the location of cancer-predisposing genes on chromosome 17 in both inherited and somatic mutations for breast cancer: gene linkage studies in families with multiple affected members and allelic composition studies comparing tumors with normal tissues for loss of heterozygosity (Fig. 1) . Two genes have recently been implicated in the development of hereditary breast cancer, the tumor-suppressor gene p53 (56) (57) (58) (59) (60) , which maps to chromosome 17pl3.1, and the breast-cancer-suppressor gene BRCA1 (61) , which was originally identified by linkage to the anonymous DNA marker D17S74 at 17q21 (62) and appears to be involved in the largest proportion of inherited breast cancer. For noninherited breast cancer, the role of xenoestrogenic or xenobiotic exposures for oncogene activation or gene suppression needs to be carefully evaluated.
Discussion
How can we explain the fact that the generation of women who had their children earlier in life and had more of them now have higher rates of breast cancer? Obviously, known risk factors do not completely account for breast cancer patterns in industrialized countries (4) . The great preponderance of these factors, such as early age of menses, late age of menopause, reproductive history, and caloric intake relative to body weight, can be linked to total lifetime exposure to bioavailable estrogen. 45 , after which the rate of increase forms a hook and levels off or declines for about 10 years and then resumes an increasing, but more modest slope (64) . The ages of this plateau correspond to the period of perimenopause, when the ovaries begin to produce less estrogen and progestin. It is tempting to speculate that the renewed surge in breast cancer after menopause, especially in obese women, might be linked with xenoestrogens and with the production of endogenous estrogens, which would be greatest in those with proportionally more body fat.
A recent series of studies on the possible link of environmental hormones with male reproductive disorders bears mention (65) . Reported disorders of the male reproductive tract, including reduced sperm counts and testicular cancer, have increased over the past several decades (66) . Could prenatal exposures to xenoestrogens be involved? Evidence from a number of fields points to the profound importance of endogenous and xenobiotic materials for the production of estrogen and other hormones. Future research will need to span disciplines to discern the extent to which human activities affect hormones throughout our lives.
With respect to breast cancer, most of the confirmed risk factors, which relate to reproductive behavior and dietary factors, are not easily changed by social policy. Many of the proposed interventions to reduce breast cancer involve the lifelong use of pharmaceutical agents or the advocacy of radical changes in diet, lifestyle, or even reproductive behavior. As to the latter point, a generation of women that has struggled long for reproductive freedom is unlikely to embrace suggestions that constrain reproductive choices. Research to pinpoint preventable causes of breast cancer is critically needed. If xenoestrogens do play a role in breast cancer, reductions in exposure will provide an opportunity for primary prevention of this growing disease.
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